DaVita Quarterly Income Statements Chart
Quarterly
|
Annual
DaVita Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dialysis patient service revenues | 3,206,871,000 | 3,102,993,000 | 3,119,180,000 | 3,138,561,000 | 3,061,102,000 | 2,760,034,000 | 2,972,272,000 | 2,951,950,000 | 2,890,685,000 | 2,760,034,000 | 2,803,590,000 | 2,846,494,000 | 2,810,099,000 | 2,716,281,000 | 2,843,031,000 | 2,837,940,000 | 2,817,957,000 | 2,714,587,000 | 2,773,123,000 | 2,781,650,000 | 2,758,197,000 | 2,713,281,000 | |||||||||||||||||||||||||||||||||||||||||||||
| other revenues | 172,655,000 | 120,536,000 | 175,503,000 | 125,029,000 | 125,620,000 | 112,665,000 | 173,475,000 | 169,382,000 | 109,684,000 | 112,665,000 | 113,298,000 | 102,200,000 | 116,658,000 | 101,274,000 | 100,936,000 | 100,379,000 | 98,553,000 | 105,414,000 | 132,199,000 | 142,416,000 | 121,782,000 | 127,956,000 | 132,575,000 | 126,886,000 | 118,889,000 | 113,423,000 | 105,070,000 | 188,606,000 | 217,956,000 | 232,825,000 | 405,124,000 | 283,969,000 | 288,417,000 | 290,852,000 | 290,283,000 | 347,180,000 | 360,599,000 | 325,556,000 | 350,474,000 | 294,236,000 | 310,814,000 | 264,799,000 | 274,415,000 | 259,716,000 | 273,923,000 | 224,310,000 | 220,696,000 | 200,100,000 | 202,856,000 | 173,695,000 | 133,799,000 | 184,406,000 | 174,897,000 | 155,943,000 | |||||||||||||
| total revenues | 3,379,526,000 | 3,223,529,000 | 3,294,683,000 | 3,263,590,000 | 3,186,722,000 | 2,872,699,000 | 3,145,747,000 | 3,121,332,000 | 3,000,369,000 | 2,872,699,000 | 2,916,888,000 | 2,948,694,000 | 2,926,757,000 | 2,817,555,000 | 2,943,967,000 | 2,938,319,000 | 2,916,510,000 | 2,820,001,000 | 2,905,322,000 | 2,924,066,000 | 2,879,979,000 | 2,841,237,000 | 2,898,584,000 | 2,904,078,000 | 2,842,705,000 | 2,743,112,000 | 2,821,124,000 | 2,847,330,000 | 2,886,953,000 | 2,849,444,000 | |||||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patient care costs | 2,261,540,000 | 2,239,660,000 | 2,225,371,000 | 2,151,875,000 | 2,142,299,000 | 2,058,189,000 | 2,138,369,000 | 2,067,315,000 | 2,055,844,000 | 2,058,189,000 | 2,088,681,000 | 2,085,555,000 | 2,016,788,000 | 2,018,529,000 | 2,060,218,000 | 2,008,589,000 | 1,965,277,000 | 1,938,330,000 | 2,056,881,000 | 1,971,719,000 | 1,984,564,000 | 1,975,449,000 | 2,000,625,000 | 1,991,172,000 | 1,957,753,000 | 1,964,935,000 | 1,953,929,000 | 1,662,529,000 | 1,340,918,000 | 1,312,247,000 | 1,263,159,000 | 1,213,912,000 | 1,189,638,000 | 1,165,220,000 | 1,115,996,000 | 1,135,012,000 | 1,146,382,000 | 1,110,552,000 | 1,082,789,000 | 1,095,046,000 | 1,095,857,000 | 1,051,879,000 | 1,005,886,000 | ||||||||||||||||||||||||
| general and administrative | 412,805,000 | 374,090,000 | 414,482,000 | 393,534,000 | 367,845,000 | 331,614,000 | 401,471,000 | 376,883,000 | 364,016,000 | 331,614,000 | 379,711,000 | 365,447,000 | 315,219,000 | 294,820,000 | 322,723,000 | 293,095,000 | 298,091,000 | 281,426,000 | 304,519,000 | 363,280,000 | 316,209,000 | 263,576,000 | 278,425,000 | 298,736,000 | 275,338,000 | 250,813,000 | 268,532,000 | 336,299,000 | 264,094,000 | 266,529,000 | -110,087,000 | 400,018,000 | 382,315,000 | 391,780,000 | 412,484,000 | 406,890,000 | 386,895,000 | 386,429,000 | 404,817,000 | 353,492,000 | 352,025,000 | 341,801,000 | 355,987,000 | 322,822,000 | 298,636,000 | 284,061,000 | 318,827,000 | 305,138,000 | 268,110,000 | 291,372,000 | 271,367,000 | 201,198,000 | 214,621,000 | 207,389,000 | 193,210,000 | 182,638,000 | 163,793,000 | 151,602,000 | 157,578,000 | 148,041,000 | 136,104,000 | 137,277,000 | 137,161,000 | 134,931,000 | 132,166,000 | 127,273,000 | |
| depreciation and amortization | 174,704,000 | 176,451,000 | 174,102,000 | 187,014,000 | 175,661,000 | 178,071,000 | 195,277,000 | 188,423,000 | 183,672,000 | 178,071,000 | 194,068,000 | 194,414,000 | 171,176,000 | 172,944,000 | 174,763,000 | 170,462,000 | 169,689,000 | 165,701,000 | 161,486,000 | 156,894,000 | 157,376,000 | 154,679,000 | 158,467,000 | 155,915,000 | 152,242,000 | 148,528,000 | 155,157,000 | 146,000,000 | 147,079,000 | 142,799,000 | -33,616,000 | 203,283,000 | 200,038,000 | 190,206,000 | 188,777,000 | 181,739,000 | 180,381,000 | 169,355,000 | 163,330,000 | 162,062,000 | 158,843,000 | 153,789,000 | 153,253,000 | 149,196,000 | 145,907,000 | 142,579,000 | 139,474,000 | 132,765,000 | 130,589,000 | 125,909,000 | 107,601,000 | 80,586,000 | 77,807,000 | 75,975,000 | 72,987,000 | 67,558,000 | 64,470,000 | 62,037,000 | 60,071,000 | 58,486,000 | 58,353,000 | 57,468,000 | 56,865,000 | 56,813,000 | 58,185,000 | 57,123,000 | |
| equity investment income | -7,364,000 | -5,609,000 | -10,315,000 | -3,711,000 | -5,481,000 | -6,820,000 | -5,362,000 | -7,228,000 | -8,454,000 | -6,820,000 | -1,824,000 | -8,509,000 | -9,141,000 | -7,046,000 | -3,152,000 | -8,704,000 | -7,023,000 | -8,058,000 | -6,920,250 | -5,496,000 | -4,342,000 | -17,843,000 | -4,514,000 | -2,708,000 | -155,000 | -3,935,000 | -7,925,000 | -4,237,000 | -1,387,000 | -7,601,000 | -2,783,000 | -5,033,000 | -2,908,000 | -4,542,000 | -5,225,000 | -6,095,000 | -7,372,000 | -8,319,000 | -9,223,000 | -7,649,000 | -9,367,000 | -8,063,000 | -3,064,000 | -2,618,000 | -2,632,000 | -2,221,000 | -2,619,000 | -2,417,000 | -1,519,000 | -2,031,000 | -1,789,000 | -2,834,000 | -1,376,000 | -708,000 | |||||||||||||
| gain on changes in ownership interests | -8,112,750 | 1,506,000 | -33,957,000 | 17,129,000 | -17,129,000 | -6,273,000 | -374,374,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 2,841,685,000 | 2,784,592,000 | 2,729,321,000 | 2,728,712,000 | 2,680,324,000 | 2,561,054,000 | 2,755,838,000 | 2,625,393,000 | 2,595,078,000 | 2,561,054,000 | 2,660,636,000 | 2,636,907,000 | 2,494,042,000 | 2,479,247,000 | 2,554,552,000 | 2,463,442,000 | 2,426,034,000 | 2,377,399,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| operating income | 537,841,000 | 438,937,000 | 565,362,000 | 534,878,000 | 506,398,000 | 311,645,000 | 389,909,000 | 495,939,000 | 405,291,000 | 311,645,000 | 256,252,000 | 311,787,000 | 432,715,000 | 338,308,000 | 389,415,000 | 474,877,000 | 490,476,000 | 442,602,000 | 381,671,000 | 437,669,000 | 409,920,000 | 465,376,000 | 462,588,000 | 378,336,000 | 461,886,000 | 340,507,000 | 387,908,000 | 289,038,000 | 438,192,000 | 410,686,000 | 738,726,000 | -192,523,000 | 378,316,000 | 888,236,000 | 381,428,000 | 819,156,000 | 329,070,000 | 364,889,000 | 244,935,000 | 509,368,000 | 480,548,000 | -64,156,000 | 452,085,000 | 437,536,000 | 484,295,000 | 441,225,000 | 484,179,000 | 377,074,000 | 522,020,000 | 166,861,000 | 387,623,000 | 340,859,000 | 247,882,000 | 320,720,000 | 330,112,000 | 318,712,000 | 247,046,000 | 235,553,000 | 255,405,000 | 256,591,000 | 242,365,000 | 242,666,000 | 238,712,000 | 245,001,000 | 235,954,000 | 220,604,000 | |
| yoy | 6.21% | 40.85% | 45.00% | 7.85% | 24.95% | 0.00% | 52.16% | 59.06% | -6.34% | -7.88% | -34.20% | -34.34% | -11.78% | -23.56% | 2.03% | 8.50% | 19.65% | -4.89% | -17.49% | 15.68% | -11.25% | 36.67% | 19.25% | 30.89% | 5.41% | -17.09% | -47.49% | -250.13% | 15.83% | -53.76% | 93.67% | -123.50% | 14.97% | 143.43% | 55.73% | 60.82% | -31.52% | -668.75% | -45.82% | 16.42% | -0.77% | -114.54% | -6.63% | 16.03% | -7.23% | 164.43% | 24.91% | 10.62% | 110.59% | -47.97% | 17.42% | 6.95% | 0.34% | 36.16% | 29.25% | 24.21% | 1.93% | -2.93% | 6.99% | 4.73% | 2.72% | 10.00% | |||||
| qoq | 22.53% | -22.36% | 5.70% | 5.62% | 62.49% | -20.07% | -21.38% | 22.37% | 30.05% | 21.62% | -17.81% | -27.95% | 27.91% | -13.12% | -18.00% | -3.18% | 10.82% | 15.96% | -12.79% | 6.77% | -11.92% | 0.60% | 22.27% | -18.09% | 35.65% | -12.22% | 34.21% | -34.04% | 6.70% | -44.41% | -483.71% | -150.89% | -57.41% | 132.87% | -53.44% | 148.93% | -9.82% | 48.97% | -51.91% | 6.00% | -849.03% | -114.19% | 3.33% | -9.66% | 9.76% | -8.87% | 28.40% | -27.77% | 212.85% | -56.95% | 13.72% | 37.51% | -22.71% | -2.85% | 3.58% | 29.01% | 4.88% | -7.77% | -0.46% | 5.87% | -0.12% | 1.66% | -2.57% | 3.83% | 6.96% | ||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt expense | -146,062,000 | -135,055,000 | -138,721,000 | -134,583,000 | -97,747,000 | -100,774,000 | -96,190,000 | -98,080,000 | -103,507,000 | -100,774,000 | -100,962,000 | -99,680,000 | -82,586,000 | -73,791,000 | -72,087,000 | -72,829,000 | -73,324,000 | -67,014,000 | -60,469,000 | -73,658,000 | -81,381,000 | -88,603,000 | -92,050,000 | -88,589,000 | -131,666,000 | -131,519,000 | -128,300,000 | -125,927,000 | -119,692,000 | -113,516,000 | -108,620,000 | -109,623,000 | -107,962,000 | -104,429,000 | -104,023,000 | -104,581,000 | -102,894,000 | -102,884,000 | -103,259,000 | -103,481,000 | -104,248,000 | -97,392,000 | -97,949,000 | -99,878,000 | -106,132,000 | -106,335,000 | -107,609,000 | -108,421,000 | -108,096,000 | -105,817,000 | -95,970,000 | -70,494,000 | -60,709,000 | -61,381,000 | -61,750,000 | -60,848,000 | -59,897,000 | -58,595,000 | -53,879,000 | -39,490,000 | -43,655,000 | -44,583,000 | -44,831,000 | -45,535,000 | -47,088,000 | -48,301,000 | |
| debt prepayment, extinguishment and modification costs | -10,081,000 | -9,732,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other loss | -22,851,000 | -17,549,000 | -12,908,000 | -16,780,000 | -3,631,250 | -19,650,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income before income taxes | 368,928,000 | 286,333,000 | 279,165,000 | 373,434,000 | 371,440,000 | 214,623,000 | 222,006,750 | 378,209,000 | 295,195,000 | 214,623,000 | 204,696,250 | 207,209,000 | 348,845,000 | 262,731,000 | 191,470,250 | -297,776,000 | 275,607,000 | 788,050,000 | 278,072,000 | 716,451,000 | 229,391,000 | 264,981,000 | 144,207,250 | 408,371,000 | 330,539,000 | -162,081,000 | 187,705,000 | 177,799,000 | 132,362,000 | 217,860,000 | 195,322,000 | 198,914,000 | 194,563,000 | 200,465,000 | 190,139,000 | 173,057,000 | |||||||||||||||||||||||||||||||
| income tax expense | 93,708,000 | 54,117,000 | 64,488,000 | 77,674,000 | 71,688,000 | 43,955,000 | 58,495,000 | 68,848,000 | 48,818,000 | 43,955,000 | 34,330,000 | 42,515,000 | 64,229,000 | 57,013,000 | 65,508,000 | 74,704,000 | 81,309,000 | 85,211,000 | 73,368,000 | 65,792,000 | 83,212,000 | 91,560,000 | 81,690,000 | 65,254,000 | 75,938,000 | 56,746,000 | 51,748,000 | 52,047,000 | 83,868,000 | 70,737,000 | 113,982,000 | 287,765,000 | 89,802,000 | 104,301,000 | 134,888,000 | 111,833,000 | 147,064,000 | 122,762,000 | 103,977,000 | 116,628,000 | 100,887,000 | 124,851,000 | 135,747,000 | 100,930,000 | 129,192,000 | 15,144,000 | 97,707,000 | 98,634,000 | 68,009,000 | 95,495,000 | 91,710,000 | 94,204,000 | 67,040,000 | 63,047,000 | 39,917,000 | 74,979,000 | 71,429,000 | 73,914,000 | 68,980,000 | 74,195,000 | 70,507,000 | 64,783,000 | |||||
| net income | 275,220,000 | 232,216,000 | 349,245,000 | 295,760,000 | 299,752,000 | 170,668,000 | 230,572,000 | 309,361,000 | 246,377,000 | 170,668,000 | 126,615,000 | 164,694,000 | 284,616,000 | 205,718,000 | 249,432,000 | 319,754,000 | 351,031,000 | 291,545,000 | 234,370,000 | 217,540,000 | 254,872,000 | 287,895,000 | 302,962,000 | 201,688,000 | 327,157,000 | 189,487,000 | -101,843,000 | -96,668,000 | 306,322,000 | 225,229,000 | 340,679,000 | -172,034,000 | 161,625,000 | 500,285,000 | 188,270,000 | 612,150,000 | 94,503,000 | 138,159,000 | 34,474,000 | 261,307,000 | 207,777,000 | -76,148,000 | 250,388,000 | 219,784,000 | 181,421,000 | 211,737,000 | 244,273,000 | 169,836,000 | 283,358,000 | 59,734,000 | 183,800,000 | 172,550,000 | 95,337 | 140,120 | 573,065,122 | 135,361 | 120,665,000 | 114,752,000 | 92,445,000 | 142,881,000 | 123,893,000 | 125,000,000 | 125,583,000 | 126,270,000 | 119,632,000 | 108,274,000 | |
| yoy | -8.18% | 36.06% | 51.47% | -4.40% | 21.66% | 0.00% | 82.10% | 87.84% | -13.44% | -17.04% | -49.24% | -48.49% | -18.92% | -29.44% | 6.43% | 46.99% | 37.73% | 1.27% | -22.64% | 7.86% | -22.09% | 51.93% | -397.48% | -308.64% | 6.80% | -15.87% | -129.89% | -43.81% | 89.53% | -54.98% | 80.95% | -128.10% | 71.03% | 262.11% | 446.12% | 134.26% | -54.52% | -281.43% | -86.23% | 18.89% | 14.53% | -135.96% | 2.50% | 29.41% | -35.97% | 254.47% | 32.90% | -1.57% | 297117.24% | 42530.60% | -67.93% | 127373.94% | -99.92% | -99.88% | 519.90% | -99.91% | -2.61% | -8.20% | -26.39% | 13.16% | 3.56% | 15.45% | |||||
| qoq | 18.52% | -33.51% | 18.08% | -1.33% | 75.63% | -25.98% | -25.47% | 25.56% | 44.36% | 34.79% | -23.12% | -42.13% | 38.35% | -17.53% | -21.99% | -8.91% | 20.40% | 24.40% | 7.74% | -14.65% | -11.47% | -4.97% | 50.21% | -38.35% | 72.65% | -286.06% | 5.35% | -131.56% | 36.00% | -33.89% | -298.03% | -206.44% | -67.69% | 165.73% | -69.24% | 547.76% | -31.60% | 300.76% | -86.81% | 25.76% | -372.86% | -130.41% | 13.92% | 21.15% | -14.32% | -13.32% | 43.83% | -40.06% | 374.37% | -67.50% | 6.52% | 180889.54% | -31.96% | -99.98% | 423260.59% | -99.89% | 5.15% | 24.13% | -35.30% | 15.33% | -0.89% | -0.46% | -0.54% | 5.55% | 10.49% | ||
| net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: net income attributable to noncontrolling interests | -75,883,000 | -69,299,000 | -89,916,000 | -81,072,000 | -77,076,000 | -55,121,000 | -79,907,000 | -62,729,000 | -67,686,000 | -55,121,000 | -58,512,000 | -59,328,000 | -59,807,000 | -43,596,000 | -61,959,000 | -60,000,000 | -57,211,000 | -54,142,000 | -60,597,000 | -58,866,000 | -53,270,000 | -48,302,000 | -58,091,000 | -58,418,000 | -53,606,000 | -40,198,000 | -47,929,000 | -40,128,000 | -39,046,000 | -46,543,000 | -37,283,000 | -42,442,000 | -34,624,000 | -52,588,000 | -30,544,000 | -40,818,000 | -41,121,000 | -40,725,000 | -40,474,000 | -45,435,000 | -37,300,000 | -34,469,000 | -42,368,000 | -35,662,000 | -33,738,000 | -28,448,000 | -31,995,000 | -33,208,000 | -28,982,000 | -29,570,000 | -27,961,000 | -27,829,000 | -24,667,000 | -24,763,000 | -28,009,000 | -26,485,000 | -20,650,000 | -20,250,000 | -23,425,000 | -23,494,000 | -16,040,000 | -15,577,000 | -15,859,000 | -15,340,000 | -13,813,000 | -12,063,000 | |
| net income attributable to davita inc. | 199,337,000 | 162,917,000 | 259,329,000 | 214,688,000 | 222,676,000 | 115,547,000 | 150,665,000 | 246,632,000 | 178,691,000 | 115,547,000 | 68,103,000 | 105,366,000 | 224,809,000 | 162,122,000 | 187,473,000 | 259,754,000 | 293,820,000 | 237,403,000 | 173,773,000 | 158,674,000 | 201,602,000 | 239,593,000 | 244,871,000 | 143,270,000 | 273,551,000 | 149,289,000 | -149,772,000 | -136,796,000 | 267,276,000 | 178,686,000 | 303,396,000 | -214,476,000 | 127,001,000 | 447,697,000 | 157,726,000 | 571,332,000 | 95,044,500 | 144,721,000 | 95,337,000 | 140,120,000 | 148,123,000 | 135,361,000 | 100,015,000 | 94,502,000 | 69,020,000 | 119,387,000 | 107,853,000 | 109,423,000 | 109,724,000 | 110,930,000 | 105,819,000 | 96,211,000 | |||||||||||||||
| earnings per share attributable to davita inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income | 2.62 | 2.05 | 3.16 | 2.56 | 2.56 | 1.28 | 1.67 | 2.7 | 1.96 | 1.28 | 0.79 | 1.16 | 2.38 | 1.68 | 1.89 | 2.48 | 2.76 | 2.18 | |||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income | 2.58 | 2 | 3.07 | 2.5 | 2.5 | 1.25 | 1.62 | 2.62 | 1.91 | 1.25 | 0.78 | 1.13 | 2.3 | 1.61 | 1.82 | 2.36 | 2.64 | 2.09 | |||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average shares for earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic shares | 75,943 | 79,368 | -1,132 | 83,721 | 86,899 | 90,497 | -147 | 91,322 | 90,984 | 90,497 | -967 | 91,160 | 94,457 | 96,342 | -1,455 | 104,793 | 106,364 | 109,014 | |||||||||||||||||||||||||||||||||||||||||||||||||
| diluted shares | 77,362 | 81,275 | -1,148 | 85,795 | 88,950 | 92,483 | -135 | 94,041 | 93,418 | 92,483 | -1,319 | 93,263 | 97,772 | 100,503 | -1,718 | 109,838 | 111,423 | 113,852 | |||||||||||||||||||||||||||||||||||||||||||||||||
| gain on changes in ownership interest | -8,786,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | -27,479,000 | 3,752,000 | 1,373,000 | 3,752,000 | -7,797,000 | -4,898,000 | -1,284,000 | -1,786,000 | -2,388,000 | -7,590,000 | 15,188,000 | 1,168,000 | 6,169,000 | 5,395,000 | 9,545,000 | -4,350,000 | 11,485,000 | 5,280,000 | 5,643,000 | 6,940,000 | -494,000 | 4,007,000 | 1,994,000 | 4,582,000 | 3,799,000 | 4,370,000 | 5,253,000 | 4,243,000 | 667,000 | 1,876,000 | 3,215,000 | 2,976,000 | 4,631,000 | 2,484,000 | 2,311,000 | -533,000 | 229,000 | -1,246,000 | 1,693,000 | 1,698,000 | 3,450,000 | 2,113,000 | -1,374,000 | 598,000 | 1,039,000 | 819,000 | 840,000 | 1,039,000 | 787,000 | 798,000 | 556,000 | 841,000 | 1,091,000 | 759,000 | 739,000 | 831,000 | 682,000 | 999,000 | 1,273,000 | 754,000 | |||||||
| debt extinguishment and modification costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt prepayment and refinancing charges | -7,962,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss on changes in ownership interest | 4,063,000 | 16,252,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt prepayment, refinancing and redemption charges | -86,074,000 | -21,242,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations before income taxes | 314,940,000 | 394,458,000 | 432,340,000 | 376,756,000 | 327,371,000 | 283,332,000 | 338,084,000 | 369,475,000 | 382,023,000 | 273,785,000 | 323,703,000 | 215,928,000 | 259,114,000 | 167,118,000 | 320,494,000 | 301,752,000 | 354,365,000 | 336,412,000 | 282,308,000 | 336,588,000 | 380,020,000 | 270,766,000 | 412,550,000 | 61,642,000 | 281,729,000 | 271,184,000 | 188,013,000 | 260,378,000 | 269,149,000 | 258,662,000 | |||||||||||||||||||||||||||||||||||||
| net income from continuing operations | 249,432,000 | 319,754,000 | 351,031,000 | 291,545,000 | 254,003,000 | 217,540,000 | 254,872,000 | 277,915,000 | 300,333,000 | 208,531,000 | 247,765,000 | 159,182,000 | 207,366,000 | 115,071,000 | 236,626,000 | 231,015,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| net income from discontinued operations, net of tax | -19,633,000 | 9,980,000 | 25,713,500 | -6,843,000 | 79,392,000 | 30,305,000 | -309,209,000 | -211,739,000 | 69,696,000 | -5,786,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income from continuing operations | 1.89 | 2.48 | 2.76 | 2.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income from continuing operations | 1.82 | 2.36 | 2.64 | 2.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| amounts attributable to davita inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income from discontinued operations | -19,633 | 9,980 | 2,629 | -6,843 | 79,328 | 29,035 | -310,104 | -210,167 | 67,673 | -12,329 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt refinancing charges | -2,948,000 | -97,548,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses and charges: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| goodwill impairment charges | 83,855,000 | 41,037,000 | 3,106,000 | 63,250,000 | 176,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses and charges | 2,523,651,000 | 2,486,397,000 | 2,470,059,000 | 2,375,861,000 | 2,435,996,000 | 2,525,742,000 | 2,380,819,000 | 2,402,605,000 | 2,433,216,000 | 2,558,292,000 | 2,448,761,000 | 2,438,758,000 | -1,359,683,000 | 4,115,354,000 | 3,499,161,000 | 2,809,047,000 | 3,334,314,000 | 2,911,420,000 | 3,388,581,000 | 3,216,247,000 | 3,288,654,000 | 3,016,297,000 | 2,954,070,000 | 3,352,121,000 | 2,875,932,000 | 2,814,288,000 | 2,688,194,000 | 2,601,551,000 | 2,579,030,000 | 2,622,512,000 | 2,349,653,000 | 2,662,721,000 | 2,039,316,000 | 1,622,107,000 | 1,681,858,000 | 1,545,915,000 | 1,532,206,000 | 1,489,157,000 | 1,464,483,000 | 1,370,405,000 | 1,394,012,000 | 1,395,058,000 | 1,344,542,000 | 1,316,752,000 | 1,329,492,000 | 1,328,914,000 | 1,283,087,000 | 1,227,036,000 | |||||||||||||||||||
| basic net income from continuing operations per share | 1.203 | 1.31 | 1.65 | 1.84 | 1.73 | 1 | 1.17 | 0.72 | 0.97 | 0.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income per share | 1.223 | 1.31 | 1.65 | 1.92 | 1.78 | 0.95 | 1.64 | 0.9 | -0.86 | -0.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income from continuing operations per share | 1.18 | 1.28 | 1.62 | 1.81 | 1.73 | 0.99 | 1.16 | 0.72 | 0.96 | 0.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income per share | 1.2 | 1.28 | 1.62 | 1.89 | 1.77 | 0.95 | 1.64 | 0.9 | -0.85 | -0.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average shares for earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 120,905,038 | 122,074,452 | 124,901,671 | 153,180,908 | 150,675,465 | 166,346,041 | 166,387,958 | 170,785,999 | 166,770,664 | 171,617,238 | 178,957,865 | 188,625,559 | 188,883,922 | 191,088,216 | 192,376,735 | 201,641,173 | 203,761,433 | 204,497,970 | 204,366,869 | 211,867,714 | 212,374,897 | 212,991,606 | 213,387,253 | 212,301,827 | 212,617,238 | 212,258,994 | 211,375,232 | 209,939,364 | 210,394,560 | 104,898,667 | 104,484,476 | 96,017,939 | 94,979,858 | 94,171,583 | 93,769,092 | 94,658,027 | 93,441,620 | 95,488,449 | 96,263,802 | 101,504,373 | 102,608,844 | 103,003,623 | 103,364,869 | 103,603,885 | 104,127,334 | 103,705,683 | 103,878,417 | ||||||||||||||||||||
| diluted | 123,953,879 | 124,068,278 | 126,894,847 | 153,812,064 | 151,295,950 | 166,799,525 | 166,780,657 | 172,364,581 | 167,262,358 | 174,105,884 | 181,834,547 | 191,348,533 | 188,883,922 | 193,987,983 | 195,281,014 | 204,904,656 | 206,961,450 | 208,047,172 | 207,928,096 | 216,251,807 | 216,691,461 | 217,606,198 | 213,387,253 | 216,927,681 | 217,236,493 | 216,720,944 | 216,118,922 | 214,763,887 | 214,902,860 | 107,424,582 | 107,063,633 | 97,971,080 | 96,634,620 | 96,002,190 | 95,729,105 | 96,532,110 | 95,171,225 | 97,657,578 | 98,378,371 | 103,059,171 | 104,022,458 | 104,449,065 | 104,765,600 | 104,167,685 | 104,607,318 | 103,925,843 | 104,409,026 | ||||||||||||||||||||
| dialysis and related lab patient service revenues | 2,037,596,500 | 2,781,169,000 | 2,734,065,000 | 2,635,152,000 | 2,729,803,000 | 2,670,701,000 | 2,718,403,000 | 2,591,074,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| benefit from uncollectible accounts | -2,026,000 | -3,977,000 | -10,249,000 | -5,463,000 | -13,749,000 | -11,977,000 | -49,406,000 | 25,545,000 | -5,652,000 | -2,685,000 | -606,000 | 1,910,000 | 1,821,000 | 3,773,000 | 3,566,000 | 2,517,000 | 2,743,000 | 2,511,000 | 2,159,000 | 1,827,000 | 4,773,000 | 3,961,000 | 3,208,000 | 2,511,000 | 1,216,000 | 1,498,000 | 1,260,000 | 878,000 | -1,955,000 | 2,469,000 | 1,801,000 | 2,024,000 | 54,318,000 | 51,942,000 | 49,417,000 | 42,289,000 | 43,382,000 | 43,938,000 | 42,367,000 | 41,563,000 | 41,796,000 | 42,021,000 | 41,233,000 | 36,736,000 | |||||||||||||||||||||||
| net dialysis and related lab patient service revenues | 2,032,674,250 | 2,777,192,000 | 2,723,816,000 | 2,629,689,000 | 2,716,054,000 | 2,658,724,000 | 2,668,997,000 | 2,616,619,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| equity investment (income) loss | -1,521,000 | -3,936,000 | -9,795,000 | -3,614,000 | -2,345,000 | -376,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| investment and other asset impairments | 6,093,000 | 11,245,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| impairment of other assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt prepayment charges | -12,160,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patient care costs and other costs | 2,027,069,000 | 2,063,770,000 | 2,069,089,000 | 2,035,585,000 | -868,701,000 | 2,925,975,000 | 2,859,911,000 | 2,722,820,000 | 2,695,749,000 | 2,697,629,000 | 2,671,025,000 | 2,582,333,000 | 2,515,131,000 | 2,501,015,000 | 2,446,076,000 | 2,362,612,000 | 2,366,461,000 | 2,326,534,000 | 2,246,538,000 | 2,179,772,000 | 2,127,832,000 | 2,095,334,000 | 2,014,320,000 | ||||||||||||||||||||||||||||||||||||||||||||
| equity investment loss | -1,531,500 | 3,824,000 | 11,337,000 | 4,852,000 | 505,000 | 18,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gain on settlement | -131,706,750 | -526,827,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income from continuing operations per share attributable to davita inc. | 1.16 | 1.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income per share attributable to davita inc. | 1.56 | 1 | 1.63 | -1.14 | 0.66 | 2.33 | 0.82 | 2.8 | 1.008 | 1.52 | 1.01 | 1.49 | 1.58 | 1.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income from continuing operations per share attributable to davita inc. | 1.15 | 1.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income per share attributable to davita inc. | 1.53 | 0.98 | 1.61 | -1.14 | 0.65 | 2.29 | 0.81 | 2.76 | 0.99 | 1.5 | 0.99 | 1.46 | 1.56 | 1.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| patient service revenues | 2,007,525,500 | 2,746,257,000 | 2,682,467,000 | 2,601,378,000 | 2,676,108,000 | 2,629,661,000 | 2,570,654,000 | 2,477,738,000 | 2,430,851,000 | 2,414,034,000 | 2,363,579,000 | 2,271,815,000 | 2,324,458,000 | 2,242,533,000 | 2,187,249,000 | 2,114,098,000 | 2,151,972,000 | 2,126,699,000 | 2,048,651,000 | 1,979,873,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| less: benefit from uncollectible accounts | -133,170,000 | -123,760,000 | -115,485,000 | -112,983,000 | -115,165,000 | -115,555,000 | -111,428,000 | -109,205,000 | -113,279,000 | -109,452,000 | -105,965,000 | -99,164,000 | -96,664,000 | -98,971,000 | -88,052,000 | -83,197,000 | -76,821,000 | -74,477,000 | -72,191,000 | -70,057,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| net patient service revenues | 1,919,468,500 | 2,622,497,000 | 2,566,982,000 | 2,488,395,000 | 2,560,943,000 | 2,514,106,000 | 2,459,226,000 | 2,368,533,000 | 2,317,572,000 | 2,304,582,000 | 2,257,614,000 | 2,172,651,000 | 2,227,794,000 | 2,143,562,000 | 2,099,197,000 | 2,030,901,000 | 2,075,151,000 | 2,052,222,000 | 1,976,460,000 | 1,909,816,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| capitated revenues | 739,119,750 | 1,016,365,000 | 1,022,078,000 | 918,036,000 | 864,516,000 | 869,290,000 | 897,826,000 | 887,047,000 | 865,543,000 | 926,847,000 | 866,190,000 | 850,515,000 | 825,808,000 | 848,546,000 | 799,369,000 | 787,565,000 | 767,362,000 | 747,264,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| total net revenues | -620,957,000 | 3,922,831,000 | 3,877,477,000 | 3,697,283,000 | 3,715,742,000 | 3,730,576,000 | 3,717,651,000 | 3,581,136,000 | 3,533,589,000 | 3,525,665,000 | 3,434,618,000 | 3,287,965,000 | 3,328,017,000 | 3,251,824,000 | 3,172,489,000 | 3,042,776,000 | 3,063,209,000 | 2,999,586,000 | 2,871,673,000 | 2,829,582,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| goodwill and asset impairment charges | 175,380,750 | 601,040,000 | 61,117,000 | 39,366,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax (benefit) expense | 69,001,250 | -125,742,000 | -85,933,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| settlement charge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt redemption charges | -1,031,750 | -4,127,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gain on sales of business interests | -29,791,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to davita healthcare partners inc. | 53,382,000 | 97,434,000 | -6,000,000 | 215,872,000 | 170,477,000 | -110,617,000 | 208,020,000 | 184,122,000 | 147,683,000 | 183,289,000 | 212,278,000 | 136,628,000 | 254,376,000 | 30,164,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income per share attributable to davita healthcare partners inc. | 0.26 | 0.48 | -0.03 | 1.02 | 0.8 | -0.52 | 0.98 | 0.87 | 0.7 | 0.87 | 1.01 | 0.65 | 2.42 | 0.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted net income per share attributable to davita healthcare partners inc. | 0.26 | 0.47 | -0.02 | 1 | 0.78 | -0.52 | 0.95 | 0.85 | 0.68 | 0.85 | 0.99 | 0.64 | 2.37 | 0.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| goodwill impairment charge | 77,000,000 | 24,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax benefit | 126,822,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss contingency accrual and settlement charge | 123,750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| debt redemption and refinancing charges | -48,072,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss contingency accrual | 495,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss contingency reserve | 4,250,000 | 17,000,000 | 300,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| contingent earn-out obligation adjustment | -56,977,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations | 250,388,000 | 219,784,000 | 181,421,000 | 211,737,000 | 244,273,000 | 169,836,000 | 283,358,000 | 46,498,000 | 184,022,000 | 172,550,000 | 120,004,000 | 164,883,000 | 177,439,000 | 164,458,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income from operations of discontinued operations, net of tax | -139,000 | -239,000 | 1,076,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gain on disposal of discontinued operations, net of tax | 13,375,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic income from continuing operations per share attributable to davita healthcare partners inc. | 0.98 | 0.87 | 0.7 | 0.87 | 1 | 0.65 | 2.42 | 0.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted income from continuing operations per share attributable to davita healthcare partners inc. | 0.95 | 0.85 | 0.68 | 0.85 | 0.99 | 0.64 | 2.37 | 0.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| amounts attributable to davita healthcare partners inc.: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations | 13,249 | -1,307 | -2,831 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss contingency reserve and other legal settlements | 97,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| hcp capitated revenues | 692,357,000 | 746,071,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| dialysis patient service operating revenues | 1,352,550,000 | 1,838,363,000 | 1,809,259,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| less: benefit from uncollectible accounts related to patient service operating revenues | -41,806,750 | -59,803,000 | -54,416,000 | -53,008,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net patient service operating revenues | 1,310,743,250 | 1,778,560,000 | 1,754,843,000 | 1,710,692,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total net operating revenues | 1,439,835,250 | 1,962,966,000 | 1,929,740,000 | 1,866,635,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| legal proceeding contingency accrual and related expenses | 19,500,000 | 78,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss on disposal of discontinued operations, net of tax | -1,068,000 | -3,688,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic income from continuing operations per share attributable to davita inc. | 1.008 | 1.52 | 1.01 | 1.49 | 1.59 | 1.48 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted income from continuing operations per share attributable to davita inc. | 0.99 | 1.5 | 0.99 | 1.46 | 1.56 | 1.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income. | 120,004,000 | 164,883,000 | 99,315,750 | 161,846,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| patient service operating revenues | 1,763,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net operating revenues | 1,862,318,000 | 1,807,869,000 | 1,711,529,000 | 1,605,958,000 | 1,649,417,000 | 1,651,649,000 | 1,586,907,000 | 1,559,418,000 | 1,568,204,000 | 1,573,915,000 | 1,519,041,000 | 1,447,640,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic earnings per share attributable to davita inc. | 1.05 | 0.98 | 0.73 | 1.16 | 1.05 | 1.05 | 1.07 | 1.07 | 1.02 | 0.93 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per share attributable to davita inc. | 1.03 | 0.96 | 0.72 | 1.15 | 1.04 | 1.04 | 1.06 | 1.06 | 1.02 | 0.92 |
We provide you with 20 years income statements for DaVita stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DaVita stock. Explore the full financial landscape of DaVita stock with our expertly curated income statements.
The information provided in this report about DaVita stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.